VEA
SWTX

Virtus ETF Advisers’s SpringWorks Therapeutics SWTX Stock Holding History

Virtus ETF Advisers’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,037
Closed -$327K – 757
2024
Q4 		$327K Buy
9,037
+622
+7% +$21.7K 0.13% 232
2024
Q3 		$270K Hold
8,415
– – 0.13% 238
2024
Q2 		$317K Sell
8,415
-2,572
-23% -$108K 0.16% 220
2024
Q1 		$541K Buy
10,987
+1,581
+17% +$73.1K 0.29% 169
2023
Q4 		$343K Buy
9,406
+5,816
+162% +$152K 0.22% 193
2023
Q3 		$83K Sell
3,590
-356
-9% -$9.73K 0.05% 354
2023
Q2 		$103K Sell
3,946
-368
-9% -$9.67K 0.06% 366
2023
Q1 		$111K Sell
4,314
-1,664
-28% -$48.6K 0.06% 330
2022
Q4 		$155K Buy
5,978
+827
+16% +$20.4K 0.08% 334
2022
Q3 		$147K Buy
5,151
+40
+0.8% +$1.15K 0.06% 355
2022
Q2 		$126K Buy
5,111
+2,823
+123% +$103K 0.05% 368
2022
Q1 		$129K Sell
2,288
-137
-6% -$7.84K 0.06% 250
2021
Q4 		$150K Sell
2,425
-215
-8% -$14.2K 0.06% 348
2021
Q3 		$167K Sell
2,640
-134
-5% -$10.3K 0.07% 317
2021
Q2 		$229K Sell
2,774
-1,232
-31% -$93.5K 0.09% 244
2021
Q1 		$295K Buy
4,006
+66
+2% +$5.17K 0.12% 243
2020
Q4 		$286K Sell
3,940
-3,228
-45% -$208K 0.12% 232
2020
Q3 		$342K Sell
7,168
-981
-12% -$41.8K 0.18% 193
2020
Q2 		$342K Sell
8,149
-4,299
-35% -$153K 0.16% 273
2020
Q1 		$336K Sell
12,448
-1,805
-13% -$58.8K 0.14% 214
2019
Q4 		$549K Buy
+14,253
New +$334K 0.09% 198

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Virtus ETF Advisers's SWTX Position: Q1 2025 in Review

Virtus ETF Advisers sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 9,037 shares — an estimated $327K sold.

Virtus ETF Advisers first reported a position in SWTX in Q4 2019 and held it in 21 quarters. The position peaked at $549K in Q4 2019. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • Virtus ETF Advisers reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 9,037 SpringWorks Therapeutics shares in Q1 2025, an estimated $327K.
  • Virtus ETF Advisers first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 21 quarters.
  • Virtus ETF Advisers's SpringWorks Therapeutics position peaked at $549K in Q4 2019.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.